- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- 【Updated on June 30, 2025】Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Urinary Metabolites of Valproic Acid in Epileptic Patients
Bibliographic Information
- Other Title
-
- てんかん患者の尿中バルプロ酸代謝物
Search this article
Description
P(論文)
6人のてんかん患者の尿中バルプロ酸濃度及びその代謝物(3-ケト体、3-ヒドロキシ体、グルクロン酸抱合体)をガスクロマトグラフー質量分析法により同時定量した。バルプロ酸を大量に服用している患者(2名)では、尿中のグルクロン酸抱合体の排泄量が顕著に増大していた。
The urinary excretion of valproic acid (VPA) and its metabolites (3-keto VPA, 3-OH VPA, and VPA-glucuronide) in 6 epileptic patients was studied using gas chromatography-mass spectrometry. The amount of VPA and 3-OH VPA excreted in the urine was low (0.1 - 0.5 % of the dose of VPA and 0.6 - 1.5 % of the dose of 3-OH administered). The amount of 3-keto VPA and glucuronide (VPA-Glu) excreted was marked (5.8 - 26.2 % and 13.1 - 88.7 % of the dose of VPA administered, respectively). The urinary excretion of VPA and its metabolites by patients who have taken a normal amount of a VPA preparation was almost the same as that of healthy volunteers. Two epileptic patients who took a large amount of the VPA preparation showed a high excretion of VPA-Glu without an increase in their plasma VPA-Glu.
Journal
-
- Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University
-
Annual report of the Faculty of Pharmacy & Pharmaceutical Sciences, Fukuyama University 17 94-, 1999
- Tweet
Details 詳細情報について
-
- CRID
- 1050282812577152768
-
- NII Article ID
- 120005499741
-
- NII Book ID
- AN10064550
-
- Text Lang
- ja
-
- Article Type
- departmental bulletin paper
-
- Data Source
-
- IRDB
- CiNii Articles